| 货号 | 规格 | 价格 | 上海 | 北京 | 珠海 | 重庆 | 武汉 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
S80228-5mg促销 |
≥99% | ￥950.00 ￥760.00 |
6 | - | - | - | - |
|
S80228-10mg促销 |
≥99% | ￥1540.00 ￥1230.00 |
4 | - | - | - | - |
|
S80228-25mg促销 |
≥99% | ￥3280.00 ￥2620.00 |
2 | - | - | - | - |
|
S80228-50mg促销 |
≥99% | ￥5760.00 ￥4600.00 |
1 | - | - | - | - |
|
S80228-100mg促销 |
≥99% | ￥9730.00 ￥7780.00 |
2 | - | - | - | - |
|
| 产品描述： | Nemiralisib (GSK2269557 free base) is a potent and highly selective PI3Kδ inhibitor with a pKi of 9.9. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | PI3Kδ:9.9 (pKi);PI3Kγ:5.2 (pIC50);PI3Kα:5.3 (pIC50);PI3Kβ:5.8 (pIC50);PI3K | ||||||||||||||||||||
| 体内研究： | To assess the suitability of the series for inhaled delivery clearance data in rat microsomes and subsequently in vivo pharmacokinetic data from Sprague Dawley male rats is obtained. Compounds (e.g., Nemiralisib) are administered by the oral or intravenous routes, at a dose level of 3 and 1mg/kg respectively (n=2 rats/route). Nemiralisib free base is active in a disease relevant brown norway rat acute OVA model of Type 2 helper T-cells (Th2)-driven lung inflammation | ||||||||||||||||||||
| 参考文献： | 1. Down K et al. Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease. J Med Chem. 2015 Sep 24;58(18):7381-99. | ||||||||||||||||||||
| 溶解性： | Soluble in DMSO | ||||||||||||||||||||
| 保存条件： | -20℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京